Genitourinary Drugs Market Is Witnessing Significant Growth Due To High R&D Investments Undertaken By The Key Companies Till 2024
The genitourinary drugs market is expected to reach USD 29.7 billion by 2024, according to a new study by Grand View Research, Inc. This sector is expected to be driven by high R&D investments undertaken by the key companies, which is expected to result in the large-scale development of new drug candidates. This is presumed to increase the influx of drugs at a rapid pace into the genitourinary drugs market hence providing efficient treatment alternatives for numerous genitourinary disorders. Genitourinary drugs market, by product, 2013 - 2024 (USD Million) In addition, growing incidence of drug recalls is fueling the high clinical urgency to develop relatively new and advanced drugs with targeted therapy mechanisms. These factors cumulatively are slated to present the vertical with considerable growth opportunities over the forecast period. Furthermore, increasing global presence of the major market players is anticipated to raise the awareness levels p...